Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AKU

Akumin (AKU) Stock Price, News & Analysis

Akumin logo

About Akumin Stock (NASDAQ:AKU)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.13
$0.36
52-Week Range
N/A
Volume
8.54 million shs
Average Volume
1.38 million shs
Market Capitalization
$26.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.

Receive AKU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akumin and its competitors with MarketBeat's FREE daily newsletter.

AKU Stock News Headlines

Broward radiology firm names CEO
Elon Warns “America Is Broke”. Trump’s Plan Inside.
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history. Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are...
Adcore: Top 10 Undervalued Growth Stocks on TSX (ADCO)
See More Headlines

AKU Stock Analysis - Frequently Asked Questions

Akumin Inc. (NASDAQ:AKU) released its earnings results on Monday, December, 13th. The company reported ($0.02) EPS for the quarter, topping analysts' consensus estimates of ($0.43) by $0.41. The business had revenue of $108.18 million for the quarter, compared to the consensus estimate of $109.25 million. Akumin had a negative net margin of 30.56% and a negative trailing twelve-month return on equity of 167.86%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Akumin investors own include Labor Smart (LTNC), NVIDIA (NVDA), Processa Pharmaceuticals (PCSA), Acrivon Therapeutics (ACRV), Canopy Growth (CGC), Aeva Technologies (AEVA) and AST SpaceMobile (ASTS).

Company Calendar

Last Earnings
12/13/2021
Today
5/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:AKU
Fax
N/A
Employees
3,631
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-156,760,000.00
Pretax Margin
-28.78%

Debt

Sales & Book Value

Annual Sales
$749.63 million
Price / Cash Flow
N/A
Book Value
$1.24 per share
Price / Book
N/A

Miscellaneous

Free Float
72,473,000
Market Cap
$26.32 million
Optionable
Not Optionable
Beta
-0.72
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:AKU) was last updated on 5/13/2025 by MarketBeat.com Staff
From Our Partners